BDBM242438 US9422235, 12

SMILES COc1cc(Nc2ccc(cc2)S(=O)(=O)NCC2CC2)cc(OC)c1

InChI Key InChIKey=GCPFDXOLQNQCTI-UHFFFAOYSA-N

Data  7 KI  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 242438   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  6nM ΔG°:  -11.4kcal/mole IC50:  11nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  97nM ΔG°:  -9.72kcal/mole IC50:  235nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  363nM ΔG°:  -8.93kcal/mole IC50:  853nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  2.68E+3nM ΔG°:  -7.72kcal/mole IC50:  6.00E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  2.68E+3nM ΔG°:  -7.72kcal/mole IC50:  6.00E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  3.00E+3nM ΔG°:  -7.66kcal/moleT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242438(US9422235, 12)
Affinity DataKi:  5.56E+3nM ΔG°:  -7.28kcal/mole IC50:  1.10E+4nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent